Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dawidowski

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
Science (New York, N.Y.)|April 1, 2017
Inhibitors of PEX14 disrupt protein import into glycosomes and kill <i>Trypanosoma</i> parasitesM Dawidowski, L Emmanouilidis, V C Kalel, et al.
European Journal of Medicinal Chemistry|October 7, 2019
Synthesis and biological evaluation of new multi-target 3-(1H-indol-3-yl)pyrrolidine-2,5-dione derivatives with potential antidepressant effectMartyna Z Wróbel, Andrzej Chodkowski, Franciszek Herold, et al.
European Journal of Medicinal Chemistry|August 12, 2009
Novel 4-aryl-pyrido[1,2-c]pyrimidines with dual SSRI and 5-HT1A activity: part 2Franciszek Herold, Łukasz Izbicki, Andrzej Chodkowski, et al.
European Journal of Medicinal Chemistry|August 6, 2011
Synthesis and biological investigation of potential atypical antipsychotics with a tropane core. Part 1Tomasz Słowiński, Jacek Stefanowicz, Maciej Dawidowski, et al.
European Journal of Medicinal Chemistry|October 4, 2022
Structure-based design, synthesis and evaluation of a novel family of PEX5-PEX14 interaction inhibitors against TrypanosomaValeria Napolitano, Piotr Mróz, Monika Marciniak, et al.
Journal of Medicinal Chemistry|December 21, 2019
Structure-Activity Relationship in Pyrazolo[4,3-<i>c</i>]pyridines, First Inhibitors of PEX14-PEX5 Protein-Protein Interaction with Trypanocidal ActivityMaciej Dawidowski, Vishal C Kalel, Valeria Napolitano, et al.
European Journal of Medicinal Chemistry|June 5, 2015
Novel 4-aryl-pyrido[1,2-c]pyrimidines with dual SSRI and 5-HT(1A) activity. Part 5Anna Gomółka, Agnieszka Ciesielska, Martyna Z Wróbel, et al.
Bioorganic Chemistry|March 16, 2020
Structure-activity relationship and cardiac safety of 2-aryl-2-(pyridin-2-yl)acetamides as a new class of broad-spectrum anticonvulsants derived from DisopyramideMaciej Dawidowski, Marek Król, Bartłomiej Szulczyk, et al.
The EMBO Journal|December 12, 2018
Inhibition of CPAP-tubulin interaction prevents proliferation of centrosome-amplified cancer cellsAruljothi Mariappan, Komal Soni, Kenji Schorpp, et al.
Minerva Medica|July 26, 2021
Interplay between climate, pollution and COVID-19 on ST-elevation myocardial infarction in a large metropolitan regionGiuseppe Biondi-Zoccai, Gaston A Rodriguez-Granillo, Juan M Mercade, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Science (New York, N.Y.)|April 1, 2017
Inhibitors of PEX14 disrupt protein import into glycosomes and kill <i>Trypanosoma</i> parasitesM Dawidowski, L Emmanouilidis, V C Kalel, et al.
European Journal of Medicinal Chemistry|October 7, 2019
Synthesis and biological evaluation of new multi-target 3-(1H-indol-3-yl)pyrrolidine-2,5-dione derivatives with potential antidepressant effectMartyna Z Wróbel, Andrzej Chodkowski, Franciszek Herold, et al.
European Journal of Medicinal Chemistry|August 12, 2009
Novel 4-aryl-pyrido[1,2-c]pyrimidines with dual SSRI and 5-HT1A activity: part 2Franciszek Herold, Łukasz Izbicki, Andrzej Chodkowski, et al.
European Journal of Medicinal Chemistry|August 6, 2011
Synthesis and biological investigation of potential atypical antipsychotics with a tropane core. Part 1Tomasz Słowiński, Jacek Stefanowicz, Maciej Dawidowski, et al.
European Journal of Medicinal Chemistry|October 4, 2022
Structure-based design, synthesis and evaluation of a novel family of PEX5-PEX14 interaction inhibitors against TrypanosomaValeria Napolitano, Piotr Mróz, Monika Marciniak, et al.
Journal of Medicinal Chemistry|December 21, 2019
Structure-Activity Relationship in Pyrazolo[4,3-<i>c</i>]pyridines, First Inhibitors of PEX14-PEX5 Protein-Protein Interaction with Trypanocidal ActivityMaciej Dawidowski, Vishal C Kalel, Valeria Napolitano, et al.
European Journal of Medicinal Chemistry|June 5, 2015
Novel 4-aryl-pyrido[1,2-c]pyrimidines with dual SSRI and 5-HT(1A) activity. Part 5Anna Gomółka, Agnieszka Ciesielska, Martyna Z Wróbel, et al.
Bioorganic Chemistry|March 16, 2020
Structure-activity relationship and cardiac safety of 2-aryl-2-(pyridin-2-yl)acetamides as a new class of broad-spectrum anticonvulsants derived from DisopyramideMaciej Dawidowski, Marek Król, Bartłomiej Szulczyk, et al.
The EMBO Journal|December 12, 2018
Inhibition of CPAP-tubulin interaction prevents proliferation of centrosome-amplified cancer cellsAruljothi Mariappan, Komal Soni, Kenji Schorpp, et al.
Minerva Medica|July 26, 2021
Interplay between climate, pollution and COVID-19 on ST-elevation myocardial infarction in a large metropolitan regionGiuseppe Biondi-Zoccai, Gaston A Rodriguez-Granillo, Juan M Mercade, et al.
Pageof 10